Passage BIO(PASG)
搜索文档
Passage Bio (PASG) Investor Presentation - Slideshow
2020-11-17 05:07
Passage Bio Corporate Presentation NOVEMBER 2020 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned IND submissions and initiation of clinical trials; our expectations about our collaborators' and partners' ability to execute ke ...
Passage BIO(PASG) - 2020 Q3 - Earnings Call Transcript
2020-11-11 02:48
Passage Bio, Inc. (NASDAQ:PASG) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Bruce Goldsmith - President and Chief Executive Officer Rich Morris - Chief Financial Officer Jill Quigley - Chief Operating Officer Gary Romano - Chief Medical Officer Conference Call Participants Anupam Rana - JPMorgan Sonia Gupta - Goldman Sachs Brendan Smith - Cowen and Company Operator Thank you for holding. Good morning and welcome to the Pass ...
Passage BIO(PASG) - 2020 Q2 - Earnings Call Transcript
2020-08-14 02:17
Passage Bio, Inc. (NASDAQ:PASG) Q2 2020 Earnings Conference Call August 13, 2020 8:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Jill Quigley - COO Bruce Goldsmith - President and CEO Rich Morris - CFO Gary Romano - Chief Medical Officer Conference Call Participants Anupam Rana - JPMorgan Andrea Tan - Goldman Sachs Yaron Werber - Cowen Operator Thank you for holding. Good morning and welcome to the Passage Bio Second Quarter 2020 Financial and Operating Results Conference Call. ...
Passage Bio (PASG) Investor Presentation - Slideshow
2020-06-12 04:02
Passage Bio Corporate Presentation JUNE 2020 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned IND submissions and initiation of clinical trials; our expectations about our collaborators' and partners' ability to execute key in ...
Passage BIO(PASG) - 2020 Q1 - Earnings Call Transcript
2020-05-12 06:22
Passage Bio, Inc. (NASDAQ:PASG) Q1 2020 Earnings Conference Call May 11, 2020 8:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Jill Quigley - COO Bruce Goldsmith - President and CEO Rich Morris - CFO Gary Romano - Chief Medical Officer Conference Call Participants Andrea Tan - Goldman Sachs Brendan Smith - Cowen and Company Anupam Rana - JPMorgan Gbola Amusa - Chardan Capital Markets Operator Ladies and gentlemen, thank you for holding. Good morning and welcome to the Passage Bi ...